According to government officials and federal data, delivery of Johnson & Johnson’s vaccine dosages across the U.S. will drop by more than 80% next week, according to government officials and federal data, as J&J is grappling with the challenges of manufacturing.
The federal government next week allocated only 700,000 doses of J&J vaccine to U.S. states, territories and certain cities and federal agencies, compared to 4.9 million doses allocated for this week, according to information provided online by the Centers for Disease Control and Prevention has been posted. .
The expected sharp decline will complicate government officials’ mass vaccination plans at a time when they are counting on a larger amount of doses to immunize the growing number of eligible people.
It is not clear why next week’s supply is declining so sharply, although federal officials have warned countries that there could be week-to-week fluctuations.
J&J recently experienced a manufacturing problem at a contract manufacturer’s factory in Baltimore – a factor cited by some government officials – but the U.S. regulator did not give permission to deliver doses to the US